Unlock your academic potential and expand your network by joining us!

Prof. Thomas Illig

Information

Thomas Illig has been the director of the Hannover Unified Biobank (HUB) since January 2012, the central biobank of Hannover Medical School (MHH). He and his team have established a modern, highly automated biobanking center, which is one of the biggest clinical biobanks in Germany. He has longstanding experience in biobanking research as well as molecular and genetic epidemiology. He pioneered work on the combination of different systematic molecular data, e.g., the combination of genome-wide association (GWAs) and metabolomics, transcriptomics, or epigenomics, leading to a better understanding of complex diseases. He has co-organized the Module “Clinical Studies and Biobanking” in the master course “Biomedical Data Sciences” at Hannover Medical School. He is actively involved in advancing the German Biobank Node (GBN) and the German Biobank Alliance (GBA), where he has been deputy speaker for six years. He is one of the speakers of the National Pandemic Cohort Network (NAPKON) which has recruited several thousand patients suffering from COVID-19. In NAPKON he is head of the Biobank Core Unit (BCU), responsible for different biosample quality aspects. He has published 646 papers with 85,288 citations and an h-index of 138 (Scopus, 1 December 2023). His research topics mainly include nutrition, DNA, gene expression, molecular biology, Genetics, Genomics, PCR, DNA Sequencing, Molecular Genetics, and sequencing.

Research Keywords & Expertise

Big Data
Biomarkers
OMICS
association analysis
biobank research

Fingerprints

Biomarkers
OMICS

Short Biography

Thomas Illig has been the director of the Hannover Unified Biobank (HUB) since January 2012, the central biobank of Hannover Medical School (MHH). He and his team have established a modern, highly automated biobanking center, which is one of the biggest clinical biobanks in Germany. He has longstanding experience in biobanking research as well as molecular and genetic epidemiology. He pioneered work on the combination of different systematic molecular data, e.g., the combination of genome-wide association (GWAs) and metabolomics, transcriptomics, or epigenomics, leading to a better understanding of complex diseases. He has co-organized the Module “Clinical Studies and Biobanking” in the master course “Biomedical Data Sciences” at Hannover Medical School. He is actively involved in advancing the German Biobank Node (GBN) and the German Biobank Alliance (GBA), where he has been deputy speaker for six years. He is one of the speakers of the National Pandemic Cohort Network (NAPKON) which has recruited several thousand patients suffering from COVID-19. In NAPKON he is head of the Biobank Core Unit (BCU), responsible for different biosample quality aspects. He has published 646 papers with 85,288 citations and an h-index of 138 (Scopus, 1 December 2023). His research topics mainly include nutrition, DNA, gene expression, molecular biology, Genetics, Genomics, PCR, DNA Sequencing, Molecular Genetics, and sequencing.